Impact of National Screening Programs on Down syndrome prevalence and outcomes
Acta Obstetricia et Gynecologica Scandinavica · 2026
DOI: 10.1111/aogs.70157 ↗At a glance
Journal article in Acta Obstetricia et Gynecologica Scandinavica, 2026. Written by Cecilie Bryn Nordklev and 5 co-authors. Institution: Fetal Medicine Centre, Oslo University Hospital, Oslo, Norway. Major MEDLINE topics: Down Syndrome, Prenatal Diagnosis. 42 references. The full text is freely available (open access, CC BY-NC-ND 4.0).
Abstract (original language)
Introduction
Over the past five decades, antenatal screening programs have evolved significantly, primarily through advancements in ultrasound technology and the shift from invasive to non‐invasive prenatal testing methods. This study aimed to evaluate the impact of these developments in prenatal screening for Down syndrome (DS) on the prevalence of live and stillbirths, as well as terminations of pregnancy (TOP) with DS. Material and Methods This population‐based registry study included all pregnancies in Norway from 1967 to 2021, with data on TOPs available from 1999. Information on DS pregnancies was obtained from the Medical Birth Registry of Norway. Logistic regression models were applied to evaluate time trends and maternal characteristics associated with TOP.
Results
Among 3 231 159 pregnancies, 4764 (0.147%) were affected by DS. The prevalence of DS pregnancies increased from 0.165% in 1999 to 0.251% in 2021. During this period, the proportion of TOP rose from 20% to 55%, while prenatal detection rates improved from 18% to 70%. Despite increased detection, the proportion of TOP following prenatal diagnosis remained stable at approximately 80%. The prevalence of live births with DS remained stable at approximately 0.106%, while the prevalence of stillbirths was around 0.008%. Maternal age, parity, country of birth, and region of residence were associated with TOP decisions. Mean gestational age at termination decreased from 17.5 to 15.7 weeks.
Conclusions
Over recent decades, prenatal detection and termination of DS pregnancies have increased. However, the proportion of women continuing pregnancies after a prenatal diagnosis and the prevalence of live‐ and stillbirths with DS have remained stable.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Fetal Medicine Centre, Oslo University Hospital, Oslo, Norway.
- Faculty of Medicine, University of Oslo, Oslo, Norway.
- Norwegian Research Centre for Women's Health, Oslo University Hospital, Oslo, Norway.
- The Cancer Registry of Norway, Norwegian Institute of Public Health, Oslo, Norway.
- Faculty of Health and Social Sciences, Western Norway University of Applied Sciences, Bergen, Norway.
- Department of Clinical Science, University of Bergen, Bergen, Norway.
ORCID profiles: Cecilie Bryn Nordklev, Denise Reis Costa, Roy Miodini Nilsen, Siri Vangen, Vasilis Sitras
Cite
APA
Nordklev, C. B., Costa, D. R., Nilsen, R. M., Morken, N. H., Vangen, S., & Sitras, V. (2026). Impact of National Screening Programs on Down syndrome prevalence and outcomes. Acta Obstetricia et Gynecologica Scandinavica. https://doi.org/10.1111/aogs.70157
Vancouver
Nordklev CB, Costa DR, Nilsen RM, Morken NH, Vangen S, Sitras V. Impact of National Screening Programs on Down syndrome prevalence and outcomes. Acta Obstetricia et Gynecologica Scandinavica. 2026. doi:10.1111/aogs.70157
BibTeX
@article{Nordklev2026,
author = {Nordklev, Cecilie Bryn and Costa, Denise Reis and Nilsen, Roy Miodini and Morken, Nils-Halvdan and Vangen, Siri and Sitras, Vasilis},
title = {Impact of National Screening Programs on Down syndrome prevalence and outcomes},
journal = {Acta Obstetricia et Gynecologica Scandinavica},
year = {2026},
doi = {10.1111/aogs.70157}
}
EUVIMED